Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
02 Jul 2021
Historique:
received: 01 06 2021
revised: 28 06 2021
accepted: 30 06 2021
entrez: 10 8 2021
pubmed: 11 8 2021
medline: 10 9 2021
Statut: epublish

Résumé

Comparative pharmacodynamic (PD) analyses on different dosing schedules for cholecalciferol supplementation are limited. This was an open-label, randomized, parallel-group study involving 75 healthy individuals deficient in vitamin D (baseline 25OHD < 20 ng/mL) receiving oral cholecalciferol with three different dosing regimens: Group A: 10,000 IU/day for 8 weeks followed by 1000 IU/day for 4 weeks; Group B: 50,000 IU/week for 12 weeks and Group C: 100,000 IU every other week for 12 weeks. Regulators of calcium and phosphate homeostasis, bone turnover markers and Wnt inhibitors were measured at baseline, Day 28, 53, 84, and 112. The 1,25OH2D increased at each time point. The increase was greater (

Identifiants

pubmed: 34371803
pii: nu13072293
doi: 10.3390/nu13072293
pmc: PMC8308331
pii:
doi:

Substances chimiques

Biomarkers 0
FGF23 protein, human 0
Phosphates 0
Vitamins 0
Cholecalciferol 1C6V77QF41
Fibroblast Growth Factor-23 7Q7P4S7RRE
Calcium SY7Q814VUP

Types de publication

Clinical Trial, Phase I Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Abiogen Pharma
ID : The study was financially supported by an unrestricted grant from Abiogen Pharma, Pisa 339 Italy.

Références

Exp Clin Endocrinol Diabetes. 2017 Oct;125(9):634-637
pubmed: 26824280
J Osteoporos. 2014;2014:682763
pubmed: 25548714
Ann Clin Biochem. 2011 Sep;48(Pt 5):418-32
pubmed: 21750113
Mayo Clin Proc. 2006 Mar;81(3):353-73
pubmed: 16529140
Endocr Rev. 2019 Aug 1;40(4):1109-1151
pubmed: 30321335
JAMA Netw Open. 2020 Nov 2;3(11):e2025850
pubmed: 33206192
Nutrients. 2020 May 27;12(6):
pubmed: 32471106
Bone. 2014 Oct;67:189-92
pubmed: 25003812
J Clin Endocrinol Metab. 2013 Dec;98(12):4619-28
pubmed: 24106283
Carcinogenesis. 2007 Sep;28(9):1877-84
pubmed: 17449905
BMJ. 2017 Feb 15;356:i6583
pubmed: 28202713
Gynecol Endocrinol. 2020 Mar;36(3):185-189
pubmed: 32093515
Int Immunopharmacol. 2018 Jun;59:227-232
pubmed: 29665496
Ann Oncol. 2019 May 1;30(5):733-743
pubmed: 30796437
Calcif Tissue Int. 2012 Dec;91(6):365-9
pubmed: 23052222
J Clin Endocrinol Metab. 2011 May;96(5):1555-9
pubmed: 21367927
Lancet. 1980 Sep 20;2(8195 pt 1):612-5
pubmed: 6107407
J Nutr Health Aging. 2015 Dec;19(10):980-5
pubmed: 26624208
Endocrinol Metab (Seoul). 2017 Dec;32(4):451-459
pubmed: 29271617
Nat Rev Endocrinol. 2017 Aug;13(8):466-479
pubmed: 28387318
Clin Sci (Lond). 2020 Sep 30;134(18):2521-2534
pubmed: 32936248
PLoS One. 2017 Jan 23;12(1):e0169620
pubmed: 28114352
Anticancer Res. 2008 Sep-Oct;28(5A):2613-23
pubmed: 19035286
JAMA Netw Open. 2019 Dec 2;2(12):e1917789
pubmed: 31860103
J Clin Endocrinol Metab. 2012 Apr;97(4):E622-6
pubmed: 22298802
Nature. 1978 Nov 30;276(5687):517-9
pubmed: 723936
N Engl J Med. 2007 Jul 19;357(3):266-81
pubmed: 17634462
Int J Paleopathol. 2018 Dec;23:96-99
pubmed: 30573171
Bone. 2018 May;110:321-325
pubmed: 29486367
J Nutr. 2016 Aug;146(8):1537-45
pubmed: 27335139
Front Med (Lausanne). 2020 Sep 09;7:551
pubmed: 33015101
Clin Biochem. 2017 Dec;50(18):1306-1311
pubmed: 28847718
Anal Chem. 2010 Mar 15;82(6):2488-97
pubmed: 20151683
Int Immunopharmacol. 2019 Feb;67:487-489
pubmed: 30599401
Diabetes Care. 2020 Dec;43(12):2916-2922
pubmed: 33020052
Calcif Tissue Int. 2020 Apr;106(4):371-377
pubmed: 31897527
Clin Rheumatol. 2017 Oct;36(10):2377-2381
pubmed: 28634697
Osteoporos Int. 2008 May;19(5):663-71
pubmed: 17874029
Mol Endocrinol. 2014 May;28(5):644-58
pubmed: 24597546
J Steroid Biochem Mol Biol. 2019 Feb;186:4-21
pubmed: 30205156
J Bone Miner Res. 2017 Jul;32(7):1486-1495
pubmed: 28276596
Cells. 2020 Jan 17;9(1):
pubmed: 31963554
Best Pract Res Clin Endocrinol Metab. 2018 Oct;32(5):669-684
pubmed: 30449548
Eur J Clin Nutr. 2014 May;68(5):632-4
pubmed: 24424073
Bone. 2018 Feb;107:124-130
pubmed: 29155243
Eur J Clin Nutr. 2021 Jun;75(6):980-987
pubmed: 32855522
Eur J Endocrinol. 2014 Mar 13;170(4):645-50
pubmed: 24488080
Mol Cell Endocrinol. 2015 Sep 15;413:157-67
pubmed: 26112182
J Bone Miner Res. 2012 Nov;27(11):2259-63
pubmed: 22692843
JAMA. 2010 May 12;303(18):1815-22
pubmed: 20460620
Osteoporos Int. 2017 Feb;28(2):577-584
pubmed: 27682249

Auteurs

Angelo Fassio (A)

Rheumatology Unit, University of Verona, 37134 Verona, Italy.

Davide Gatti (D)

Rheumatology Unit, University of Verona, 37134 Verona, Italy.

Maurizio Rossini (M)

Rheumatology Unit, University of Verona, 37134 Verona, Italy.

Camilla Benini (C)

Rheumatology Unit, University of Verona, 37134 Verona, Italy.

Elena Fracassi (E)

Rheumatology Unit, University of Verona, 37134 Verona, Italy.

Eugenia Bertoldo (E)

Rheumatology Unit, University of Verona, 37134 Verona, Italy.

Ombretta Viapiana (O)

Rheumatology Unit, University of Verona, 37134 Verona, Italy.

Stefano Milleri (S)

Centro Ricerche Cliniche di Verona, 37134 Verona, Italy.

Matteo Gatti (M)

Rheumatology Unit, University of Verona, 37134 Verona, Italy.

Giovanni Adami (G)

Rheumatology Unit, University of Verona, 37134 Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH